Biotechnology Allogene Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference January 4, 2023
Biotechnology BioMarin to Present at 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, at 10:30 am PT /1:30 pm ET, in San Francisco, CA January 4, 2023
Biotechnology Online Enrollment Now Open for Physicians Requesting Expanded Access to Ascendis Pharma’s TransCon(TM) PTH for Eligible U.S. Adult Patients with Hypoparathyroidism January 4, 2023
Health Biogen and Alcyone Therapeutics Announce License and Collaboration Agreement to Evaluate a Novel Device to Improve Patient Experience and Access to Neurological ASO Therapies January 4, 2023
Health Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers January 4, 2023
Biotechnology Editas Medicine to Present at the 41st Annual J.P. Morgan Healthcare Conference January 4, 2023
Biotechnology Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Commercial Officer January 3, 2023
Search
Health
